Citations (37)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (37)
Rui Chang, Rongrong Fu, Yujiao Huang, Jibing Zhang, Changshun Feng, Rui Wang, Hui Yan, Guangyong Li, Xiaohong Chu, Fengjiao Yuan, Dianlong Jia & Jun Li. (2023) Codelivery of TRAIL and Mitomycin C via Liposomes Shows Improved Antitumor Effect on TRAIL-Resistant Tumors. Molecular Pharmaceutics 20:6, pages 2864-2875.
Crossref
Crossref
Janske Nel, Kamil Elkhoury, Émilie Velot, Arnaud Bianchi, Samir Acherar, Grégory Francius, Ali Tamayol, Stéphanie Grandemange & Elmira Arab-Tehrany. (2023) Functionalized liposomes for targeted breast cancer drug delivery. Bioactive Materials 24, pages 401-437.
Crossref
Crossref
Aliesha Moudgil, Rajesh Salve, Virendra Gajbhiye & Bhushan P. Chaudhari. (2023) Challenges and emerging strategies for next generation liposomal based drug delivery: An account of the breast cancer conundrum. Chemistry and Physics of Lipids 250, pages 105258.
Crossref
Crossref
Anna Maria Wróblewska, Jan Samsonowicz-Górski, Ewelina Kamińska, Marcin Drozd & Magdalena Matczuk. (2022) Optimization of a CE-ICP-MS/MS method for the investigation of liposome–cisplatin nanosystems and their interactions with transferrin. Journal of Analytical Atomic Spectrometry 37:7, pages 1442-1449.
Crossref
Crossref
Elaheh Mirhadi, Fatemeh Gheybi, Nadya Mahmoudi, Maliheh Hemmati, Fatemeh Soleymanian, Atefeh Ghasemi, Anis Askarizadeh, Mehrdad Iranshahi, Mahmoud Reza Jaafari & Seyedeh Hoda Alavizadeh. (2022) Amino acid coordination complex mediates cisplatin entrapment within PEGylated liposome: An implication in colorectal cancer therapy. International Journal of Pharmaceutics 623, pages 121946.
Crossref
Crossref
Theodora Amanda Seidu, Perpetua Takunda Kutoka, Dorothy Owusu Asante, Muhammad Asim Farooq, Raphael N. Alolga & Wang Bo. (2022) Functionalization of Nanoparticulate Drug Delivery Systems and Its Influence in Cancer Therapy. Pharmaceutics 14:5, pages 1113.
Crossref
Crossref
Victoria O. Shipunova & Sergey M. Deyev. (2022) Artificial Scaffold PolypeptidesAs an Efficient Tool for the Targeted Delivery of Nanostructures In Vitro and In Vivo. Acta Naturae 14:1, pages 54-72.
Crossref
Crossref
Leila Sayed-Tabatabaei, Jaleh Varshosaz, Shaghayegh Haghjooy Javanmard & Sahel Soghrati. (2022) Camouflaged liposomes by 11A4-nanobody for co-delivery of cisplatin and nitroxoline in breast cancer tumors: An in vitro/in vivo study. Journal of Drug Delivery Science and Technology 71, pages 103273.
Crossref
Crossref
Dianlong Jia, Feifei Wang, Yujiao Yang, Ping Hu, Hao Song, Yue Lu, Rui Wang, Guangyong Li, Renmin Liu, Jun Li & Fengjiao Yuan. (2022) Coupling EGFR-Antagonistic Affibody Enhanced Therapeutic Effects of Cisplatin Liposomes in EGFR-expressing Tumor Models. Journal of Pharmaceutical Sciences 111:2, pages 450-457.
Crossref
Crossref
Amin Mehrabian, Mohammad Mashreghi, Saba Dadpour, Ali Badiee, Leila Arabi, Seyedeh Hoda Alavizadeh, Seyedeh Alia Moosavian & Mahmoud Reza Jaafari. (2022) Nanocarriers Call the Last Shot in the Treatment of Brain Cancers. Technology in Cancer Research & Treatment 21, pages 153303382210809.
Crossref
Crossref
Leila Siavoshinia, Alireza Kheirollah, Majid Zeinali, Ebrahim Barzegari & Mostafa Jamalan. (2021) Combinatorial in silico and in vivo evaluation of immune response elicitation by the affibody ZHER2. International Immunopharmacology 101, pages 108368.
Crossref
Crossref
Léna Guyon, Anne-Claire Groo & Aurélie Malzert-Fréon. (2020) Relevant Physicochemical Methods to Functionalize, Purify, and Characterize Surface-Decorated Lipid-Based Nanocarriers. Molecular Pharmaceutics 18:1, pages 44-64.
Crossref
Crossref
Komal Agrawal, Ansar Alam & Pradeep Verma. 2021. Recent Trends in Mycological Research. Recent Trends in Mycological Research
1
25
.
Elaheh Mirhadi, Mohammad Mashreghi, Mahdi Faal Maleki, Seyedeh Hoda Alavizadeh, Leila Arabi, Ali Badiee & Mahmoud Reza Jaafari. (2020) Redox-sensitive nanoscale drug delivery systems for cancer treatment. International Journal of Pharmaceutics 589, pages 119882.
Crossref
Crossref
Hana Kostrhunova, Juraj Zajac, Lenka Markova, Viktor Brabec & Jana Kasparkova. (2020)
A Multi‐action Pt
IV
Conjugate with Oleate and Cinnamate Ligands Targets Human Epithelial Growth Factor Receptor HER2 in Aggressive Breast Cancer Cells
. Angewandte Chemie International Edition.
Crossref
Crossref
Hana Kostrhunova, Juraj Zajac, Lenka Markova, Viktor Brabec & Jana Kasparkova. (2020)
A Multi‐action Pt
IV
Conjugate with Oleate and Cinnamate Ligands Targets Human Epithelial Growth Factor Receptor HER2 in Aggressive Breast Cancer Cells
. Angewandte Chemie.
Crossref
Crossref
Bahman Moradipoodeh, Mostafa Jamalan, Majid Zeinali, Masood Fereidoonnezhad & Ghorban Mohammadzadeh. (2020) Specific targeting of HER2-positive human breast carcinoma SK-BR-3 cells by amygdaline-ZHER2 affibody conjugate. Molecular Biology Reports 47:9, pages 7139-7151.
Crossref
Crossref
Dianlong Jia, Yujiao Yang, Fengjiao Yuan, Qing Fan, Feifei Wang, Yujiao Huang, Hao Song, Ping Hu, Rui Wang, Guangyong Li, Renmin Liu & Jun Li. (2020) Increasing the antitumor efficacy of doxorubicin liposomes with coupling an anti-EGFR affibody in EGFR-expressing tumor models. International Journal of Pharmaceutics 586, pages 119541.
Crossref
Crossref
Jingya Han, Yan Zhao, Xinming Zhao, Tuo Ma, Tiancheng Hao, Jiahui Liu, Zhaoqi Zhang, Jingmian Zhang & Jianfang Wang. (2019) Therapeutic efficacy and imaging assessment of the HER2-targeting chemotherapy drug ZHER2:V2-pemetrexed in lung adenocarcinoma Xenografts. Investigational New Drugs 38:4, pages 1031-1043.
Crossref
Crossref
Fatemeh Sadat Hashemi, Farin Farzadnia, Abdoreza Aghajani, Farnaz Ahmadzadeh NobariAzar & Akram Pezeshki. (2020) Conjugated linoleic acid loaded nanostructured lipid carrier as a potential antioxidant nanocarrier for food applications. Food Science & Nutrition 8:8, pages 4185-4195.
Crossref
Crossref
Gautam Kumar, Krishnadas Nandakumar, Srinivas Mutalik & Chamallamudi Mallikarjuna Rao. (2020) Biologicals to direct nanotherapeutics towards HER2-positive breast cancers. Nanomedicine: Nanotechnology, Biology and Medicine 27, pages 102197.
Crossref
Crossref
Annalisa Barozzi, R. Ashton Lavoie, Kevin N. Day, Raphael Prodromou & Stefano Menegatti. (2020) Affibody-Binding Ligands. International Journal of Molecular Sciences 21:11, pages 3769.
Crossref
Crossref
Lei Jing, Juanjuan Liu, Dongxu Cui, Yuyin Li, Zhenxing Liu, Li Tao, Qing Zhao & Aipo Diao. (2020) Screening and production of an affibody inhibiting the interaction of the PD-1/PD-L1 immune checkpoint. Protein Expression and Purification 166, pages 105520.
Crossref
Crossref
Ghaferi, Asadollahzadeh, Akbarzadeh, Ebrahimi Shahmabadi & Alavi. (2020) Enhanced Efficacy of PEGylated Liposomal Cisplatin: In Vitro and In Vivo Evaluation. International Journal of Molecular Sciences 21:2, pages 559.
Crossref
Crossref
Ledan Wang, Wangqi Du, Shanli Zhu, Pengfei Jiang & Lifang Zhang. (2019) A high-risk papillomavirus 18 E7 affibody-enabled in vivo imaging and targeted therapy of cervical cancer. Applied Microbiology and Biotechnology 103:7, pages 3049-3059.
Crossref
Crossref
Josef Jampílek & Katarína Kráľová. 2019. Nanoarchitectonics in Biomedicine. Nanoarchitectonics in Biomedicine
219
294
.
Bernhard Biersack & Rainer Schobert. 2019. Breast Cancer Metastasis and Drug Resistance. Breast Cancer Metastasis and Drug Resistance
253
270
.
Vanessa Bellat, Richard Ting, Teresa L. Southard, Linda Vahdat, Henrik Molina, Joseph Fernandez, Omer Aras, Tracy Stokol & Benedict Law. (2018) Functional Peptide Nanofibers with Unique Tumor Targeting and Enzyme-Induced Local Retention Properties. Advanced Functional Materials 28:44, pages 1803969.
Crossref
Crossref
Ian Lambert & Belinda Sørensen. (2018) Facilitating the Cellular Accumulation of Pt-Based Chemotherapeutic Drugs. International Journal of Molecular Sciences 19:8, pages 2249.
Crossref
Crossref
Anindita De, Gowthamarajan Kuppusamy & Veera Venkata Satyanarayana Reddy Karri. (2018) Affibody molecules for molecular imaging and targeted drug delivery in the management of breast cancer. International Journal of Biological Macromolecules 107, pages 906-919.
Crossref
Crossref
Muhammad Riaz, Muhammad Riaz, Xue Zhang, Congcong Lin, Ka Wong, Xiaoyu Chen, Ge Zhang, Aiping Lu & Zhijun Yang. (2018) Surface Functionalization and Targeting Strategies of Liposomes in Solid Tumor Therapy: A Review. International Journal of Molecular Sciences 19:1, pages 195.
Crossref
Crossref
Nithya Subramanian, Akilandeswari Balachandran & Krishnakumar Subramanian. 2018. Gene and Cell Therapy: Biology and Applications. Gene and Cell Therapy: Biology and Applications
147
194
.
Stefan Ståhl, Torbjörn Gräslund, Amelie Eriksson Karlström, Fredrik Y. Frejd, Per-Åke Nygren & John Löfblom. (2017) Affibody Molecules in Biotechnological and Medical Applications. Trends in Biotechnology 35:8, pages 691-712.
Crossref
Crossref
Mahdi Abastabar, Abolfazl Akbari, Javad Akhtari, Mohammad Taghi Hedayati, Tahereh Shokohi, Hasan Mehrad-Majd, Hosseein Ghalehnoei & Sahar Ghasemi. (2017) In vitro antitumor activity of patulin on cervical and colorectal cancer cell lines. Current Medical Mycology 3:1, pages 25-29.
Crossref
Crossref
Wing-Hin Lee, Ching-Yee Loo, Paul M. Young, Daniela Traini & Ramin Rohanizadeh. 2017. Particulate Technology for Delivery of Therapeutics. Particulate Technology for Delivery of Therapeutics
25
82
.
Manouchehr Teymouri, Ali Badiee, Shiva Golmohammadzadeh, Kayvan Sadri, Javad Akhtari, Mostafa Mellat, Amin Reza Nikpoor & Mahmoud Reza Jaafari. (2016) Tat peptide and hexadecylphosphocholine introduction into pegylated liposomal doxorubicin: An in vitro and in vivo study on drug cellular delivery, release, biodistribution and antitumor activity. International Journal of Pharmaceutics 511:1, pages 236-244.
Crossref
Crossref
Javad Akhtari, Seyed Mahdi Rezayat, Manouchehr Teymouri, Seyedeh Hoda Alavizadeh, Fatemeh Gheybi, Ali Badiee & Mahmoud Reza Jaafari. (2016) Targeting, bio distributive and tumor growth inhibiting characterization of anti-HER2 affibody coupling to liposomal doxorubicin using BALB/c mice bearing TUBO tumors. International Journal of Pharmaceutics 505:1-2, pages 89-95.
Crossref
Crossref